Overview

Combination Treatment for Posttraumatic Stress Disorder (PTSD) After the World Trade Center (WTC) Attack

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This randomized controlled trial evaluates efficacy of combined prolonged exposure (PE) and the selective serotonin reuptake inhibitor (SSRI) paroxetine in the treatment of survivors of the World Trade Center (WTC) attacks.
Phase:
Phase 4
Details
Lead Sponsor:
Research Foundation for Mental Hygiene, Inc.
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Paroxetine